Literature DB >> 20406540

Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.

J Röhrich1, S Zörntlein, J Becker, R Urban.   

Abstract

The Rapid Stat assay, a point-of-collection drug-testing device for detection of amphetamines, cannabinoids, cocaine, opiates, methadone, and benzodiazepines in oral fluid, was evaluated for cannabis and amphetamine-type stimulants. The Rapid Stat tests (n = 134) were applied by police officers in routine traffic checks. Oral fluid and blood samples were analyzed using gas chromatography-mass spectrometry (GC-MS) for Delta(9)-tetrahydrocannabinol, amphetamine, methamphetamine, methylenedioxymethamphetamine, methylenedioxyethylamphetamine, and methylenedioxyamphetamine. The comparison of GC-MS analysis of oral fluid with the Rapid Stat results for cannabis showed a sensitivity of 85%, a specificity of 87%, and a total confirmation rate of 87%. When compared with serum, the sensitivity of the cannabis assay decreased to 71%, the specificity to 60%, and the total confirmation rate to 66%. These findings were possibly caused by an incorrect reading of the THC test results. Comparison of the Rapid Stat amphetamine assay with GC-MS in oral fluid showed a sensitivity of 94%, a specificity of 97%, and a total confirmation rate of 97%. Compared with serum, a sensitivity of 100%, a specificity of 90%, and a total confirmation rate of 92% was found. The amphetamine assay must, therefore, be regarded as satisfactory.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406540     DOI: 10.1093/jat/34.3.155

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  6 in total

1.  On-site test for cannabinoids in oral fluid.

Authors:  Nathalie A Desrosiers; Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-08-21       Impact factor: 8.327

Review 2.  Current knowledge on cannabinoids in oral fluid.

Authors:  Dayong Lee; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2013-08-25       Impact factor: 3.345

3.  Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices.

Authors:  Nathalie A Desrosiers; Garry Milman; Damodara R Mendu; Dayong Lee; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2014-05-15       Impact factor: 4.142

4.  Identification of Potential Distinguishing Markers for the Use of Cannabis-Based Medicines or Street Cannabis in Serum Samples.

Authors:  Anne Scheunemann; Katrin Elsner; Tanja Germerott; Sergiu Groppa; Cornelius Hess; Isabelle Miederer; Alicia Poplawski; Jörg Röhrich
Journal:  Metabolites       Date:  2021-05-13

5.  Detecting cannabis use on the human skin surface via an electronic nose system.

Authors:  Andreas Voss; Katharina Witt; Tobias Kaschowitz; Wolf Poitz; Andreas Ebert; Patrik Roser; Karl-Jürgen Bär
Journal:  Sensors (Basel)       Date:  2014-07-23       Impact factor: 3.576

6.  Comparison of 3 Derivatization Methods for the Analysis of Amphetamine-Related Drugs in Oral Fluid by Gas Chromatography-Mass Spectrometry.

Authors:  Khaled M Mohamed; Abdulsallam Bakdash
Journal:  Anal Chem Insights       Date:  2017-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.